At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
00867 CMS
Market Closed 12-05 16:09:08
13.470
+0.080
+0.60%
High13.490Low13.250Vol2.39M
Open13.300D1 Closing13.390Amplitude1.79%
Mkt Cap32.87BTradable Cap32.86BTotal Shares2.44B
T/O31.94MT/O Rate0.10%Tradable Shares2.44B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled
Stock News  ·  12-03
10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled
China Medical System (00867) Reports Unchanged Share Capital and Issued Shares for November 2025
Bulletin Express  ·  12-01
China Medical System (00867) Reports Unchanged Share Capital and Issued Shares for November 2025
China Medical System Holdings' (HKG:867) one-year total shareholder returns outpace the underlying earnings growth
Simply Wall St.  ·  11-22
China Medical System Holdings' (HKG:867) one-year total shareholder returns outpace the underlying earnings growth
Riding the Hong Kong Stock Rally: Bull Market Dawns in the East 2026 – 10th Zhitong Finance Capital Markets Annual Conference Invites You to a Capital Feast
Stock News  ·  11-18
Riding the Hong Kong Stock Rally: Bull Market Dawns in the East 2026 – 10th Zhitong Finance Capital Markets Annual Conference Invites You to a Capital Feast
Exclusive Novartis Ophthalmology Deal Might Change The Case For Investing In China Medical System Holdings (SEHK:867)
Simply Wall St.  ·  11-04
Exclusive Novartis Ophthalmology Deal Might Change The Case For Investing In China Medical System Holdings (SEHK:867)
Are China Medical System Holdings Limited's (HKG:867) Mixed Financials Driving The Negative Sentiment?
Simply Wall St.  ·  11-01
Are China Medical System Holdings Limited's (HKG:867) Mixed Financials Driving The Negative Sentiment?
China Medical System (00867) Issues Monthly Return for October 2025
Bulletin Express  ·  10-31
China Medical System (00867) Issues Monthly Return for October 2025
CMS (00867): China's NMPA Accepts Marketing Application for Long-Acting Anti-IL-4Rα Monoclonal Antibody for Atopic Dermatitis
Stock News  ·  10-30
CMS (00867): China's NMPA Accepts Marketing Application for Long-Acting Anti-IL-4Rα Monoclonal Antibody for Atopic Dermatitis
China Medical System Gets NMPA Acceptance for Atopic Dermatitis Drug Application
Reuters  ·  10-30
China Medical System Gets NMPA Acceptance for Atopic Dermatitis Drug Application
China Medical System - Nda for Atopic Dermatitis Indication of Long-Acting Anti-Il-4Ra Humanized Monoclonal Antibody Injection Accepted in China
THOMSON REUTERS  ·  10-30
China Medical System - Nda for Atopic Dermatitis Indication of Long-Acting Anti-Il-4Ra Humanized Monoclonal Antibody Injection Accepted in China
CMS (867.HK; 8a8.SG) Signed a Distribution Agreement for Ophthalmic Drugs Lucentis® and Beovu®
THOMSON REUTERS  ·  10-27
CMS (867.HK; 8a8.SG) Signed a Distribution Agreement for Ophthalmic Drugs Lucentis® and Beovu®
China Medical System Enters Distribution Contract with Novartis Pharma Services for Ophthalmic Drugs
MT Newswires  ·  10-27
China Medical System Enters Distribution Contract with Novartis Pharma Services for Ophthalmic Drugs
BRIEF-China Medical System Says Entered Distribution Agreement With Novartis Pharma Services AG
Reuters  ·  10-27
BRIEF-China Medical System Says Entered Distribution Agreement With Novartis Pharma Services AG
China Medical System Holdings Limited (CMS) Announces Distribution Agreement with Novartis for Lucentis® and Beovu®
Bulletin Express  ·  10-27
China Medical System Holdings Limited (CMS) Announces Distribution Agreement with Novartis for Lucentis® and Beovu®
China Medical System - Signing a Distribution Agreement for Ophthalmic Drugs Lucentis and Beovu
THOMSON REUTERS  ·  10-27
China Medical System - Signing a Distribution Agreement for Ophthalmic Drugs Lucentis and Beovu
CMS (00867) Enters Distribution Agreement with Novartis for Ophthalmic Drugs Lucentis® and Beovu®
Stock News  ·  10-27
CMS (00867) Enters Distribution Agreement with Novartis for Ophthalmic Drugs Lucentis® and Beovu®
China Medical System - Agreement for Ranibizumab Injection and Brolucizumab Injection
THOMSON REUTERS  ·  10-27
China Medical System - Agreement for Ranibizumab Injection and Brolucizumab Injection
China Medical System - Entered Into Distribution Agreement With Novartis Pharma Services Ag
THOMSON REUTERS  ·  10-27
China Medical System - Entered Into Distribution Agreement With Novartis Pharma Services Ag
Does MG-K10’s COPD Trial Approval Change the Bull Case for China Medical System Holdings (SEHK:867)?
Simply Wall St.  ·  10-13
Does MG-K10’s COPD Trial Approval Change the Bull Case for China Medical System Holdings (SEHK:867)?
CMS (00867) Receives Clinical Trial Approval for Class 1 New Drug MG-K10 Humanized Monoclonal Antibody Injection for Chronic Obstructive Pulmonary Disease Indication
Stock News  ·  09-30
CMS (00867) Receives Clinical Trial Approval for Class 1 New Drug MG-K10 Humanized Monoclonal Antibody Injection for Chronic Obstructive Pulmonary Disease Indication

Introduction

Company Name.
CMS
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
China Medical System Holdings Ltd is an investment holding company principally engaged in the production of medicines, as well as marketing, promotion and sales of drugs. The Company's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The Company distributes its products within domestic market and to overseas markets.
Issue price:
--